1. Home
  2. TVTX vs SONO Comparison

TVTX vs SONO Comparison

Compare TVTX & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • SONO
  • Stock Information
  • Founded
  • TVTX 2008
  • SONO 2002
  • Country
  • TVTX United States
  • SONO United States
  • Employees
  • TVTX N/A
  • SONO N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • SONO Consumer Electronics/Video Chains
  • Sector
  • TVTX Health Care
  • SONO Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • SONO Nasdaq
  • Market Cap
  • TVTX 1.4B
  • SONO 1.2B
  • IPO Year
  • TVTX N/A
  • SONO 2018
  • Fundamental
  • Price
  • TVTX $14.23
  • SONO $9.92
  • Analyst Decision
  • TVTX Strong Buy
  • SONO Buy
  • Analyst Count
  • TVTX 15
  • SONO 3
  • Target Price
  • TVTX $33.57
  • SONO $13.00
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • SONO 1.5M
  • Earning Date
  • TVTX 07-31-2025
  • SONO 08-06-2025
  • Dividend Yield
  • TVTX N/A
  • SONO N/A
  • EPS Growth
  • TVTX N/A
  • SONO N/A
  • EPS
  • TVTX N/A
  • SONO N/A
  • Revenue
  • TVTX $273,533,000.00
  • SONO $1,463,138,000.00
  • Revenue This Year
  • TVTX $73.84
  • SONO N/A
  • Revenue Next Year
  • TVTX $46.72
  • SONO $3.27
  • P/E Ratio
  • TVTX N/A
  • SONO N/A
  • Revenue Growth
  • TVTX 75.65
  • SONO N/A
  • 52 Week Low
  • TVTX $6.80
  • SONO $7.63
  • 52 Week High
  • TVTX $25.29
  • SONO $15.89
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 40.17
  • SONO 49.21
  • Support Level
  • TVTX $13.88
  • SONO $9.77
  • Resistance Level
  • TVTX $15.04
  • SONO $10.49
  • Average True Range (ATR)
  • TVTX 0.67
  • SONO 0.37
  • MACD
  • TVTX 0.04
  • SONO -0.04
  • Stochastic Oscillator
  • TVTX 36.93
  • SONO 33.33

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About SONO Sonos Inc.

Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa and the Asia Pacific. Generating a majority of its revenue from the Americas.

Share on Social Networks: